CD47
Pfizer vaults into CD47 arena, buying Trillium for $2.3 billion
Phil Taylor
CD47, checkpoint inhibitors, immuno-oncology, M&A, Oncology, Pfizer, Trillium Therapeutics
0 Comment
X
Pfizer vaults into CD47 arena, buying Trillium for $2.3 billion
https://pharmaphorum.com/news/pfizer-vaults-into-cd47-arena-buying-trillium-for-2-3-billion/
2nd Macrophage-directed Therapies Summit
jenna.warren@hansonwade.com
CAR-macrophage therapies, CD47, cell therapy, macrophage, Oncology
0 Comment
X
2nd Macrophage-directed Therapies Summit
https://pharmaphorum.com/events/2nd-macrophage-directed-therapies-summit/
ALX Oncology cancer drug claims two FDA fast-track reviews
Phil Taylor
ALX Oncology, CD47, immuno-oncology, Oncology
0 Comment
X
ALX Oncology cancer drug claims two FDA fast-track reviews
https://pharmaphorum.com/news/alx-oncology-cancer-drug-claims-two-fda-fast-track-reviews/